Tesofensine exhibits nanomolar affinity for dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT), providing a broad multi-transporter interaction profile. Unlike compounds that primarily target a single transporter system, Tesofensine enables investigation of transporter pharmacology across multiple monoaminergic pathways simultaneously.

This characteristic has made it a valuable research tool for studying transporter selectivity, ligand-transporter interactions, and comparative mechanisms of monoamine reuptake inhibition.

Because Tesofensine interacts with DAT, NET, and SERT within a single molecular framework, it provides a useful model for examining the relationship between transporter occupancy, transporter selectivity, and downstream monoaminergic signaling processes. Experimental investigations frequently utilize Tesofensine to explore transporter interaction networks, multi-target pharmacology, and mechanistic differences between selective and broad-spectrum monoamine transporter inhibitors.

Tesofensine combines high-affinity interactions with DAT, NET, and SERT together with a well-characterized transporter binding profile. These properties have established it as a valuable reference compound for investigations involving monoamine transporter biology, transporter-ligand binding dynamics, structure-activity relationships, and mechanistic studies of multi-transporter inhibition systems.

Its broad activity across multiple transporter classes continues to support research into monoaminergic signaling and transporter pharmacology.